Health
Obesity drug trial: One third of participants lose 20 per cent of body weight – The New Daily
US researchers are trumpeting a new drug as a “game changer” in the management of obesity – and for once, a large, gold-standard clinical trial backs up the hype….
US researchers are trumpeting a new drug as a “game changer” in the management of obesity and for once, a large, gold-standard clinical trial backs up the hype.
A single weekly injection of the drug semaglutide, for 68 weeks, saw an average loss of 15 percent body weight in trial participants.
Those given a placebo, in tandem with a diet and exercise program, lost 2.4 per cent of their body weight.
More than a third of the participants who took the drug lost more than 20 percent of their weight.
…
-
Noosa News23 hours agoMajor crash on Gateway Motorway snarls morning commute
-
Business20 hours agoThis ASX 200 mining stock is eyeing the lithium throne
-
Noosa News18 hours agoDriver arrested after life-threatening hit-and-run on outskirts of Ipswich, Queensland
-
General21 hours agoTrump threatens Aussie medicines with bitter tax pill